Pulse rate at 2 hours · patients with acute asthma
IV + inhaled beta agonist showed no clear difference in pulse rate at 2 hours compared with inhaled beta‐agonist (moderate certainty).
1 finding from 1 review
Clinical Failure (children with a severe to moderate overall clinical assessment score at two hours) · patients with acute asthma
IV + inhaled beta agonist probably leads to lower clinical Failure (children with a severe to moderate overall… compared with inhaled beta‐agonist (moderate certainty).
1 finding from 1 review
Length of hospital stay · patients with acute asthma
1 finding from 1 review
PEF (L/min) · patients with acute asthma
1 finding from 1 review
FEV1 (L) · patients with acute asthma
1 finding from 1 review
Heart rate · patients with acute asthma
1 finding from 1 review
Clinical failure4 · patients with acute asthma
1 finding from 1 review
Number of participants experiencing one or more episode requiring treatment with oral steroids · adults and children with chronic asthma
Combination fluticasone/salmeterol showed no clear difference in participants experiencing exacerbations requiring oral steroid… compared with budesonide/formoterol (moderate certainty).
1 finding from 1 review
Hospital admissions due to exacerbations: number of participants · adults and children with chronic asthma
Combination fluticasone/salmeterol showed no clear difference in participants experiencing exacerbations requiring admission to… compared with budesonide/formoterol (moderate certainty).
1 finding from 1 review
Asthma‐related serious adverse event · adults and children with chronic asthma
Combination fluticasone/salmeterol showed no clear difference in asthma‐related serious adverse event compared with budesonide/formoterol (moderate certainty).
1 finding from 1 review
All‐cause mortality · adults and children with chronic asthma
1 finding from 1 review
Withdrawals due to adverse events · adults and children with chronic asthma
Combination fluticasone/salmeterol showed no clear difference in withdrawals (adverse events) compared with budesonide/formoterol (moderate certainty).
1 finding from 1 review
Intervention not reported
Peak exercise capacity: Power (W) · people with chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Peak exercise capacity: Peak oxygen consumption (VO2peak) (L/min) · people with chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Peak exercise test: Lactate threshold (L/min) · people with chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Peak exercise test: Isowork minute ventilation (VE) (L) · people with chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Peak exercise test: Isowork dyspnoea score · people with chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Exercise tolerance: Endurance time (min) · people with chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Functional exercise capacity: Six‐minute walk distance (m) · people with chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Health‐related Quality of Life: Dyspnoea domain of the CRQ · people with chronic obstructive pulmonary disease
1 finding from 1 review